title: Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A.
authors.forename: C
authors.initials: C
authors.lastname: Bidlingmaier
authors.forename: K
authors.initials: K
authors.lastname: Kurnik
authors.forename: C
authors.initials: C
authors.lastname: Escuriola-Ettingshausen
authors.forename: R
authors.initials: R
authors.lastname: Jager
authors.forename: R
authors.initials: R
authors.lastname: Klamroth
authors.forename: C
authors.initials: C
authors.lastname: Male
authors.forename: A
authors.initials: A
authors.lastname: Marosi
authors.forename: L
authors.initials: L
authors.lastname: Nemes
authors.forename: A
authors.initials: A
authors.lastname: von Stackelberg
authors.forename: W
authors.initials: W
authors.lastname: Kreuz
mesh_terms: D000293:Adolescent; D000328:Adult; D019774:Blood Coagulation Factor Inhibitors / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D007223:Infant; D008297:Male; D008875:Middle Aged; D055815:Young Adult; D014841:von Willebrand Factor / Q000276:immunology* / Q000627:therapeutic use
chemical_list: D019774:Blood Coagulation Factor Inhibitors; D004338:Drug Combinations; C509423:factor VIII, von Willebrand factor drug combination; D014841:von Willebrand Factor; D005169:Factor VIII